SEC Form D · filed February 3, 2022
Castle Creek Biosciences, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
W. B. Middlekauff · Exton, PAExecJeffrey S. Aronin · Chicago, ILDirectorAntonio J. Gracias · Chicago, ILDirectorMary B. Spellman · Exton, PAExecPatrick J. Morris · Chicago, ILDirectorMatthew J. Gantz · Exton, PAExec · DirectorMark J. Graf · Exton, PADirectorJennie Choboter · VANCOUVER, British Columbia, CanadaExecSD Ariston Manager, LLC · Akron, OHDirectorPedro Checa · Kirkland, WAExecMichael Parton · Grand Cayman, Cayman IslandsExec · DirectorLeon Rhule · Grand Cayman, Cayman IslandsDirectorNate Armstrong · Sarasota, FLDirectorErika L. Taylor · DENVER, CODirectorBabar J. Ghias · Exton, PAExecSharon R. Malka · Yavne, L3Exec · DirectorStephen T. Wills · Yavne, L3ExecMike Knauss · New York, NYDirectorAndrew Atherton · Tempe, AZExecSue Payton · Broomfield, CODirectorJeff Babione · Broomfield, CODirectorEvan Dreyfuss · Chicago, ILDirectorBabar J. Ghias · Exton, PAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗